Efficacy and safety of vortioxetine for the treatment of major depressive disorder: a randomised double-blind placebo-controlled study.

Wang J, Liu XF, Feng C, Bao Q, Fu HR

Open source

DOI
10.1080/13651501.2017.1397700
Published
2019 Nov
Container
International journal of psychiatry in clinical practice
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/13651501.2017.1397700,
  title = {Efficacy and safety of vortioxetine for the treatment of major depressive disorder: a randomised double-blind placebo-controlled study.},
  author = {Wang J and Liu XF and Feng C and Bao Q and Fu HR},
  year = {2019},
  journal = {International journal of psychiatry in clinical practice},
  doi = {10.1080/13651501.2017.1397700},
  url = {https://doi.org/10.1080/13651501.2017.1397700}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of vortioxetine for the treatment of major depressive disorder: a randomised double-blind placebo-controlled study.
AU  - Wang J
AU  - Liu XF
AU  - Feng C
AU  - Bao Q
AU  - Fu HR
PY  - 2019
JO  - International journal of psychiatry in clinical practice
DO  - 10.1080/13651501.2017.1397700
UR  - https://doi.org/10.1080/13651501.2017.1397700
ER  - 

APA

J, W., XF, L., C, F., Q, B., & HR, F. (2019). Efficacy and safety of vortioxetine for the treatment of major depressive disorder: a randomised double-blind placebo-controlled study.. International journal of psychiatry in clinical practice. https://doi.org/10.1080/13651501.2017.1397700

Source records